Wednesday, October 7, 2026

Semiconductor Stocks Fall to 2-Week Low as Chip Makers Cut Q1 Revenue Forecasts

The S&P 500 hit a 2-week low on November 6, 2025, driven by semiconductor stock declines. Lattice Semiconductor forecasted Q1 revenue of $158M-$172M, while AXT Inc projected Q4 revenue of $22.5M-$23.5M. Microchip Technology guided Q3 adjusted EPS to 40 cents, signaling demand weakness across the chip sector.

Semiconductor Stocks Fall to 2-Week Low as Chip Makers Cut Q1 Revenue Forecasts
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Semiconductor stocks dropped sharply on November 6, 2025, pushing the S&P 500 to its lowest level in two weeks. The sector decline followed weak revenue guidance from multiple chip manufacturers, raising concerns about demand softness heading into 2026.

Lattice Semiconductor projected Q1 2026 revenue between $158 million and $172 million. AXT Inc forecasted Q4 2025 revenue of $22.5 million to $23.5 million. Microchip Technology set Q3 adjusted earnings per share guidance at 40 cents, below analyst expectations.

The downturn reflects potential overcapacity in AI infrastructure spending. After two years of aggressive buildouts by cloud providers and enterprise customers, semiconductor demand appears to be normalizing. Cyclical patterns in chip markets typically follow 18-24 month cycles, and the late 2025 weakness aligns with historical trends.

Traders should monitor NVDA, AMD, and INTC stock performance through Q1 2026 as leading indicators. These three companies represent core exposure to AI chip demand and data center infrastructure spending. Their quarterly results will test the hypothesis that AI infrastructure overcapacity is driving sector-wide valuation compression.

The correlation between AI infrastructure announcements and semiconductor valuations has weakened since mid-2025. Major cloud providers have extended deployment timelines, and enterprise AI adoption rates have decelerated from 2024 peaks. This suggests the market is repricing growth expectations for AI hardware companies.

Revenue guidance from chip manufacturers carries high significance for tech sector indices. Semiconductors represent 12% of S&P 500 technology sector weighting, making chip stock performance a key driver of broader market direction. The November 6 decline demonstrates this correlation, with the index falling as semiconductor stocks led losses.

Investors face uncertainty about whether the downturn represents temporary overcapacity correction or the start of a prolonged demand cycle. Q1 2026 earnings reports from major chip makers will provide clarity on inventory levels, order backlogs, and customer spending patterns. Until then, volatility in semiconductor stocks is likely to persist.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com